Ironwood Pharmaceuticals Inc, Daiichi Sankyo Co Ltd, Pfizer, Progenics Pharmaceuticals Inc, Shionogi & Co., Ltd, Allergan Plc, Nektar Therapeutics, Purdue Pharma, S.L.A. Pharma AG, Mundipharma International Limited, Ono Pharmaceutical Co., Ltd, Takeda Pharmaceutical Company Limited, Theravance Biopharma Inc, Bausch Health, Cosmo Pharmaceuticals SA, Daewoong Pharmaceutical, C.B. Fleet Company, Sucampo Pharmaceuticals are manufacturers listed in the Opioid Induced Constipation (OIC) Drugs Market Report.

The Global “Opioid Induced Constipation (OIC) Drugs Market” 2024–2030 Research Report offers a detailed analysis, categorizing the market by Types (Lubiprostone, Methyl Naltrexone Bromide, Naldemedine, Alvimopan, Others) and Applications (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies). This report explores consumer requirements, preferences, and expectations. It measures the size of the Opioid Induced Constipation (OIC) Drugs market, analyses competitors, examines industry trends, and estimates growth potential. The primary goal of Opioid Induced Constipation (OIC) Drugs market research is to address complex questions related to new product development, technological innovations, emerging market trends, and technology scouting and landscaping in strategic management. Additionally, it involves developing a go-to-market strategy, which includes creating marketing plans, defining target market profiles, and implementing sales and distribution strategies. The research also assesses the competitive environment to strategically position a product according to its life cycle and innovation curve.

Market Analysis and Insights: Global Opioid Induced Constipation (OIC) Drugs Market

The global Opioid Induced Constipation (OIC) Drugs market size was valued at USD 2604.3 million in 2023 and is forecast to a readjusted size of USD 3520.9 million by 2030 with a CAGR of 4.4percentage during review period.
Although opioids are very effective for treating and managing pain, their use frequently results in opioid-induced constipation (OIC). Treatment options for OIC may be as simple as changing diet or as complicated as requiring several medicines and laxatives.
Global Opioid-Induced Constipation key players include Sanofi, Bayer, Purdue Pharm, etc. Global top three manufacturers hold a share over 45percentage .
North America is the largest market, with a share about 55percentage , followed by Europe, and Asia-Pacific, both have a share about 35 percent.
In terms of product, Lubiprostone is the largest segment, with a share about 5percentage . And in terms of application, the largest application is Pharmacy, followed by Hospital, etc.
The report includes an overview of the development of the Opioid Induced Constipation (OIC) Drugs industry chain, the market status of Hospital Pharmacies (Lubiprostone, Methyl Naltrexone Bromide), Retail Pharmacies (Lubiprostone, Methyl Naltrexone Bromide), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Opioid Induced Constipation (OIC) Drugs.
Regionally, the report analyzes the Opioid Induced Constipation (OIC) Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Opioid Induced Constipation (OIC) Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Market segmentation

Opioid Induced Constipation (OIC) Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

The major players covered in the Opioid Induced Constipation (OIC) Drugs market report are:

  • Ironwood Pharmaceuticals Inc
  • Daiichi Sankyo Co Ltd
  • Pfizer
  • Progenics Pharmaceuticals Inc
  • Shionogi & Co., Ltd
  • Allergan Plc
  • Nektar Therapeutics
  • Purdue Pharma
  • S.L.A. Pharma AG
  • Mundipharma International Limited
  • Ono Pharmaceutical Co., Ltd
  • Takeda Pharmaceutical Company Limited
  • Theravance Biopharma Inc
  • Bausch Health
  • Cosmo Pharmaceuticals SA
  • Daewoong Pharmaceutical
  • C.B. Fleet Company
  • Sucampo Pharmaceuticals

Market segment by Type, covers

  • Lubiprostone
  • Methyl Naltrexone Bromide
  • Naldemedine
  • Alvimopan
  • Others

Market segment by Application can be divided into

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

To Understand How Covid-19 Impact Is Covered in This Report – https://www.absolutereports.com/enquiry/request-covid19/27666797

Market segment by region, regional analysis covers

  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

  • Chapter 1, to describe Opioid Induced Constipation (OIC) Drugs product scope, market overview, market estimation caveats and base year.
  • Chapter 2, to profile the top manufacturers of Opioid Induced Constipation (OIC) Drugs, with price, sales, revenue and global market share of Opioid Induced Constipation (OIC) Drugs from 2019 to 2024.
  • Chapter 3, the Opioid Induced Constipation (OIC) Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analysed emphatically by landscape contrast.
  • Chapter 4, the Opioid Induced Constipation (OIC) Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
  • Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
  • Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Opioid Induced Constipation (OIC) Drugs market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
  • Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
  • Chapter 13, the key raw materials and key suppliers, and industry chain of Opioid Induced Constipation (OIC) Drugs.
  • Chapter 14 and 15, to describe Opioid Induced Constipation (OIC) Drugs sales channel, distributors, customers, research findings and conclusion.

Inquire or Share Your Questions If Any before the Purchasing This Report – https://www.absolutereports.com/enquiry/pre-order-enquiry/27666797

Questions answered in the Opioid Induced Constipation (OIC) Drugs market research report:

  • What is the Opioid Induced Constipation (OIC) Drugs market size?
  • What are the market driving factors behind the Opioid Induced Constipation (OIC) Drugs market?
  • What are the market trends and forecast for the global Opioid Induced Constipation (OIC) Drugs market?
  • What are the trends and forecasts based on market research and analysis of Opioid Induced Constipation (OIC) Drugs market segmentation by type, application, and geography?
  • Which are the major global Opioid Induced Constipation (OIC) Drugs companies?
  • What is the CAGR and Revenue expected in future?

Detailed TOC of Global Opioid Induced Constipation (OIC) Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

1 Opioid Induced Constipation (OIC) Drugs Market Overview

1.1 Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Revenue by Type: 2017 Versus 2021 Versus 2030

1.3 Market Analysis by Application

1.4 Global Market Size & Forecast

1.4.1 Global Sales in Value (2017 & 2021 & 2030)

1.4.2 Global Sales in Volume (2019-2030)

1.4.3 Global Price (2019-2030)

1.5 Global Production Capacity Analysis

1.5.1 Global Total Production Capacity (2019-2030)

1.5.2 Global Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Opioid Induced Constipation (OIC) Drugs Market Drivers

1.6.2 Opioid Induced Constipation (OIC) Drugs Market Restraints

1.6.3 Opioid Induced Constipation (OIC) Drugs Trends Analysis

2 Manufacturers Profiles

2.1 Manufacture 1

2.1.1 Manufacture 1 Details

2.1.2 Manufacture 1 Major Business

2.1.3 Manufacture 1 Opioid Induced Constipation (OIC) Drugs Product and Services

2.1.4 Manufacture 1 Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2024)

2.2 Manufacture 2

2.2.1 Manufacture 2 Details

2.2.2 Manufacture 2 Major Business

2.2.3 Manufacture 2 Opioid Induced Constipation (OIC) Drugs Product and Services

2.2.4 Manufacture 2 Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2024)

2.3 Manufacture 3

2.3.1 Manufacture 3 Details

2.3.2 Manufacture 3 Major Business

2.3.3 Manufacture 3 Opioid Induced Constipation (OIC) Drugs Product and Services

2.3.4 Manufacture 3 Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2024)

Purchase this Report (Price 3480 USD for a Single-User License) – https://www.absolutereports.com/purchase/27666797

3 Opioid Induced Constipation (OIC) Drugs Breakdown Data by Manufacturer

3.1 Global Opioid Induced Constipation (OIC) Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2024)

3.2 Global Opioid Induced Constipation (OIC) Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2024)

3.3 Key Manufacturer Market Position in Opioid Induced Constipation (OIC) Drugs

3.4 Market Concentration Rate

3.4.1 Top 3 Opioid Induced Constipation (OIC) Drugs Manufacturer Market Share in 2021

3.4.2 Top 6 Opioid Induced Constipation (OIC) Drugs Manufacturer Market Share in 2021

3.5 Global Opioid Induced Constipation (OIC) Drugs Production Capacity by Company: 2021 VS 2024

3.6 Manufacturer by Geography: Head Office and Opioid Induced Constipation (OIC) Drugs Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Opioid Induced Constipation (OIC) Drugs Market Analysis by Region

4.1 Global Market Size by Region

4.1.1 Global Sales in Volume by Region (2019-2030)

4.1.2 Global Revenue by Region (2019-2030)

4.2 North America Opioid Induced Constipation (OIC) Drugs Revenue (2019-2030)

4.3 Europe Opioid Induced Constipation (OIC) Drugs Revenue (2019-2030)

4.4 Asia-Pacific Revenue (2019-2030)

4.5 South America Revenue (2019-2030)

4.6 Middle East and Africa Revenue (2019-2030)

5 Opioid Induced Constipation (OIC) Drugs Market Segment by Type

5.1 Global Sales in Volume by Type (2019-2030)

5.2 Global Revenue by Type (2019-2030)

5.3 Global Price by Type (2019-2030)

6 Opioid Induced Constipation (OIC) Drugs Market Segment by Application

6.1 Global Sales in Volume by Application (2019-2030)

6.2 Global Revenue by Application (2019-2030)

6.3 Global Price by Application (2019-2030)

7 North America by Country, by Type, and by Application

7.1 North America Opioid Induced Constipation (OIC) Drugs Sales by Type (2019-2030)

7.2 North America Opioid Induced Constipation (OIC) Drugs Sales by Application (2019-2030)

7.3 North America Opioid Induced Constipation (OIC) Drugs Market Size by Country

7.3.1 North America Opioid Induced Constipation (OIC) Drugs Sales in Volume by Country (2019-2030)

7.3.2 North America Opioid Induced Constipation (OIC) Drugs Revenue by Country (2019-2030)

7.3.3 United States Market Size and Forecast (2019-2030)

7.3.4 Canada Market Size and Forecast (2019-2030)

7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe by Country, by Type, and by Application

8.1 Europe Opioid Induced Constipation (OIC) Drugs Sales by Type (2019-2030)

8.2 Europe Opioid Induced Constipation (OIC) Drugs Sales by Application (2019-2030)

8.3 Europe Opioid Induced Constipation (OIC) Drugs Market Size by Country

8.3.1 Europe Opioid Induced Constipation (OIC) Drugs Sales in Volume by Country (2019-2030)

8.3.2 Europe Opioid Induced Constipation (OIC) Drugs Revenue by Country (2019-2030)

8.3.3 Germany Market Size and Forecast (2019-2030)

8.3.4 France Market Size and Forecast (2019-2030)

8.3.5 United Kingdom Market Size and Forecast (2019-2030)

8.3.6 Russia Market Size and Forecast (2019-2030)

8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific by Region, by Type, and by Application

9.1 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales by Type (2019-2030)

9.2 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales by Application (2019-2030)

9.3 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Market Size by Region

9.3.1 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales in Volume by Region (2019-2030)

9.3.2 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Revenue by Region (2019-2030)

9.3.3 China Market Size and Forecast (2019-2030)

9.3.4 Japan Market Size and Forecast (2019-2030)

9.3.5 Korea Market Size and Forecast (2019-2030)

9.3.6 India Market Size and Forecast (2019-2030)

9.3.7 Southeast Asia Market Size and Forecast (2019-2030)

9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America by Region, by Type, and by Application

10.1 South America Opioid Induced Constipation (OIC) Drugs Sales by Type (2019-2030)

10.2 South America Opioid Induced Constipation (OIC) Drugs Sales by Application (2019-2030)

10.3 South America Opioid Induced Constipation (OIC) Drugs Market Size by Country

10.3.1 South America Opioid Induced Constipation (OIC) Drugs Sales in Volume by Country (2019-2030)

10.3.2 South America Opioid Induced Constipation (OIC) Drugs Revenue by Country (2019-2030)

10.3.3 Brazil Market Size and Forecast (2019-2030)

10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales by Type (2019-2030)

11.2 Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales by Application (2019-2030)

11.3 Middle East & Africa Opioid Induced Constipation (OIC) Drugs Market Size by Country

11.3.1 Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales in Volume by Country (2019-2030)

11.3.2 Middle East & Africa Opioid Induced Constipation (OIC) Drugs Revenue by Country (2019-2030)

11.3.3 Turkey Market Size and Forecast (2019-2030)

11.3.4 Egypt Market Size and Forecast (2019-2030)

11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)

11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Raw Material and Industry Chain

12.1 Raw Material of Opioid Induced Constipation (OIC) Drugs and Key Manufacturers

12.2 Manufacturing Costs Percentage of Opioid Induced Constipation (OIC) Drugs

12.3 Opioid Induced Constipation (OIC) Drugs Production Process

12.4 Opioid Induced Constipation (OIC) Drugs Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.2 Opioid Induced Constipation (OIC) Drugs Typical Distributors

13.3 Opioid Induced Constipation (OIC) Drugs Typical Customers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Research Process and Data Source

15.3 Disclaimer

Contact Us:

Absolute Reports

Phone : US +1 (888) 690-5999

UK +44 8083 023308

Web : https://www.absolutereports.com

Information contained on this page is provided by an independent third-party content provider. XPRMedia and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact [email protected]